Skip to main content

Provider

By Laura Lovett | 05:03 pm | September 24, 2019
Boston Medical Center CEO Kate Walsh and Christiana Health CEO Dr. Janice Nevin discuss the future of virtual care in supporting vulnerable populations. 
By HIMSS TV | 04:10 pm | September 24, 2019
Truly impactful innovations understand and directly address a problem in care, argues Neil Gomes of Thomas Jefferson University and Jefferson Health.
By HIMSS TV | 09:44 am | September 24, 2019
Mark Jackson, VP at NantHealth, was at Health 2.0 looking for new opportunities to bring valuable cloud-based data to physicians at the point of care.
By HIMSS TV | 05:01 pm | September 23, 2019
Deep Dive: The right culture, engagement, time frames and leadership must all be aligned, and EMRAM should provide the roadmap to benchmark your organization digitally.
By Dave Muoio | 03:33 pm | September 23, 2019
Doctors on Call, a house call service proving care over the last 50 years for senior patients, will be joining the app-driven startup.
By HIMSS TV | 07:30 am | September 23, 2019
Deep Dive: The second video of this four-part series on healthcare cybersecurity looks at the motivations behind healthcare cyberattacks and the specific prizes hackers are targeting.
By Dave Muoio | 12:26 pm | September 20, 2019
At Health 2.0, a panel of hospital leaders describe the approaches vendors and startups should take when reaching out with a new product.
By HIMSS TV | 12:26 pm | September 20, 2019
Poppy Crum, chief scientist at Dolby Laboratories, talks about a future where ubiquitous sensors anticipate physical and mental health needs.
By HIMSS TV | 05:38 pm | September 19, 2019
The goal of Health 2.0, the Personal Connected Health Alliance and other initiatives is to make leading-edge technology work for patients, says HIMSS Executive Director of Health Innovation Kerry Amato.
By HIMSS TV | 02:13 pm | September 19, 2019
Sana Health wins the Health 2.0 VentureConnect award for its wearable therapeutic device that uses pulsed light and sound to reduce pain and potentially treat neurological conditions, says CEO Richard Hanbury.